Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cronos Group (CRON)
NASDAQ:CRON
Cronos Group (CRON) Stock Price & Analysis
5,132 Followers
CRON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.64 - $3.12
Previous Close$2.9
Volume463.00
Average Volume (3M)3.39M
Market Cap
$1.12B
Enterprise Value$246.44M
Total Cash (Recent Filing)$861.53M
Total Debt (Recent Filing)$2.55M
Price to Earnings (P/E)-19.4
Beta0.84
Next Earnings
Aug 08, 2024EPS Estimate
>-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding381,298,853
10 Day Avg. Volume3,059,652
30 Day Avg. Volume3,391,182
Standard Deviation0.16
R-Squared0.14
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.05
Price to Sales (P/S)12.68
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.85
Enterprise Value/Gross Profit19.38
Enterprise Value/Ebitda-10.98
Forecast
1Y Price Target
$2.72Price Target Upside-6.85% Downside
Rating ConsensusHold
Number of Analyst Covering5
Cronos Group News
PremiumCompany Announcements
Cronos Group Soars with Robust Q1 Earnings
PremiumPress Releases
Cronos Enters United Kingdom Cannabis Market
Bulls Say, Bears Say
Bulls Say
Market OutlookCannabis stocks rally on growing optimism for reform with expectations of increased medical cannabis sales due to regulatory changes in Germany and Israel, and potential rule alterations in Canada.
Product SuccessCronos reports impressive success with new value-add products under the Spinach brand, indicating robust product innovation and market acceptance.
Strategic MergersCronos shareholders could benefit from the upside potential if the company engages in a strategic merger with another cannabis firm, particularly if the deal is structured in stock.
Bears Say
Financial PerformanceCronos' financial performance has shown trends of worsening in the fourth quarter, with a drop in gross margins and high selling, general and administrative expenses, raising concerns about long-term value creation.
Market DynamicsDue to the ongoing conflict and increased competition in Israel, sales forecasts for Cronos have been reduced, which could negatively impact the stock's performance.
Regulatory EnvironmentAnalyst remains cautious on US reform, as an election year normally adds to the gridlock in Congress, potentially delaying progress in the cannabis industry.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was $1.64 and its highest was $3.12 in the past 12 months.
What is Cronos Group’s market cap?
Currently, no data Available
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Aug 08, 2024 which is in 84 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on May 09, 2024. The company reported -$0.01 earnings per share for the quarter, the consensus estimate of -$0.01 by $0.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Overvalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is >-$0.01.
How many shares outstanding does Cronos Group have?
Cronos Group has 382,011,170 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of -$0.01 in its last earnings report, expectations of -$0.01. Following the earnings report the stock price went up 10.465%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in CRON
---
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.72 (-6.85% Downside)
$2.72 (-6.85% Downside)
Blogger Sentiment
Bullish
CRON Sentiment 84%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days >0.1%
Last 30 Days ▲ 6.9%
Last 30 Days ▲ 6.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
64.77%
12-Months-Change
Fundamentals
Return on Equity
-4.91%
Trailing 12-Months
Asset Growth
-4.40%
Trailing 12-Months
Company Description
Cronos Group
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
---
CRON Earnings Call
Q1 2024
0:00 / 0:00
---
CRON Stock 12 Month Forecast
Average Price Target
$2.72
▼(-6.85% Downside)
Technical Analysis
Best Analysts Covering CRON
1 Year
1 Year Success Rate
13/20 ratings generated profit
1 Year Average Return
+15.58%
reiterated a buy rating 7 days ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 65.00% of your transactions generating a profit, with an average return of +15.58% per trade.
---